Impact of sentinel lymphadenectomy on survival in a murine model of melanoma

Robert B Rebhun, Alexander J F Lazar, Isaiah J. Fidler, Jeffrey E. Gershenwald

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Lymphatic mapping and sentinel lymph node biopsy-also termed sentinel lymphadenectomy (SL)-has become a standard of care for patients with primary invasive cutaneous melanoma. This technique has been shown to provide accurate information about the disease status of the regional lymph node basins at risk for metastasis, provide prognostic information, and provide durable regional lymph node control. The potential survival benefit afforded to patients undergoing SL is controversial. Central to this controversy is whether metastasis to regional lymph nodes occurs independent of or prior to widespread hematogenous dissemination. A related area of uncertainty is whether tumor cells residing within regional lymph nodes have increased metastatic potential. We have used a murine model of primary invasive cutaneous melanoma based on injection of B16-BL6 melanoma cells into the pinna to address two questions: (1) does SL plus wide excision of the primary tumor result in a survival advantage over wide excision alone; and (2) do melanoma cells growing within lymph nodes produce a higher incidence of hematogenous metastases than do cells growing at the primary tumor site? We found that SL significantly improved the survival of mice with small primary tumors. We found no difference in the incidence of lung metastases produced by B16-BL6 melanoma cells growing exclusively within regional lymph nodes and cells growing within the pinna.

Original languageEnglish (US)
Pages (from-to)191-199
Number of pages9
JournalClinical and Experimental Metastasis
Volume25
Issue number3
DOIs
StatePublished - May 2008
Externally publishedYes

Fingerprint

Lymph Node Excision
Melanoma
Lymph Nodes
Survival
Neoplasm Metastasis
Experimental Melanomas
Neoplasms
Sentinel Lymph Node Biopsy
Skin
Incidence
Standard of Care
Uncertainty
cyhalothrin
Lung
Injections

Keywords

  • Lymph node metastasis
  • Melanoma
  • Sentinel lymph node biopsy
  • Sentinel lymphadenectomy
  • Survival

ASJC Scopus subject areas

  • Cancer Research

Cite this

Impact of sentinel lymphadenectomy on survival in a murine model of melanoma. / Rebhun, Robert B; Lazar, Alexander J F; Fidler, Isaiah J.; Gershenwald, Jeffrey E.

In: Clinical and Experimental Metastasis, Vol. 25, No. 3, 05.2008, p. 191-199.

Research output: Contribution to journalArticle

Rebhun, Robert B ; Lazar, Alexander J F ; Fidler, Isaiah J. ; Gershenwald, Jeffrey E. / Impact of sentinel lymphadenectomy on survival in a murine model of melanoma. In: Clinical and Experimental Metastasis. 2008 ; Vol. 25, No. 3. pp. 191-199.
@article{edd1b8769c394b839f75e117d85f2492,
title = "Impact of sentinel lymphadenectomy on survival in a murine model of melanoma",
abstract = "Lymphatic mapping and sentinel lymph node biopsy-also termed sentinel lymphadenectomy (SL)-has become a standard of care for patients with primary invasive cutaneous melanoma. This technique has been shown to provide accurate information about the disease status of the regional lymph node basins at risk for metastasis, provide prognostic information, and provide durable regional lymph node control. The potential survival benefit afforded to patients undergoing SL is controversial. Central to this controversy is whether metastasis to regional lymph nodes occurs independent of or prior to widespread hematogenous dissemination. A related area of uncertainty is whether tumor cells residing within regional lymph nodes have increased metastatic potential. We have used a murine model of primary invasive cutaneous melanoma based on injection of B16-BL6 melanoma cells into the pinna to address two questions: (1) does SL plus wide excision of the primary tumor result in a survival advantage over wide excision alone; and (2) do melanoma cells growing within lymph nodes produce a higher incidence of hematogenous metastases than do cells growing at the primary tumor site? We found that SL significantly improved the survival of mice with small primary tumors. We found no difference in the incidence of lung metastases produced by B16-BL6 melanoma cells growing exclusively within regional lymph nodes and cells growing within the pinna.",
keywords = "Lymph node metastasis, Melanoma, Sentinel lymph node biopsy, Sentinel lymphadenectomy, Survival",
author = "Rebhun, {Robert B} and Lazar, {Alexander J F} and Fidler, {Isaiah J.} and Gershenwald, {Jeffrey E.}",
year = "2008",
month = "5",
doi = "10.1007/s10585-008-9141-y",
language = "English (US)",
volume = "25",
pages = "191--199",
journal = "Clinical and Experimental Metastasis",
issn = "0262-0898",
publisher = "Springer Netherlands",
number = "3",

}

TY - JOUR

T1 - Impact of sentinel lymphadenectomy on survival in a murine model of melanoma

AU - Rebhun, Robert B

AU - Lazar, Alexander J F

AU - Fidler, Isaiah J.

AU - Gershenwald, Jeffrey E.

PY - 2008/5

Y1 - 2008/5

N2 - Lymphatic mapping and sentinel lymph node biopsy-also termed sentinel lymphadenectomy (SL)-has become a standard of care for patients with primary invasive cutaneous melanoma. This technique has been shown to provide accurate information about the disease status of the regional lymph node basins at risk for metastasis, provide prognostic information, and provide durable regional lymph node control. The potential survival benefit afforded to patients undergoing SL is controversial. Central to this controversy is whether metastasis to regional lymph nodes occurs independent of or prior to widespread hematogenous dissemination. A related area of uncertainty is whether tumor cells residing within regional lymph nodes have increased metastatic potential. We have used a murine model of primary invasive cutaneous melanoma based on injection of B16-BL6 melanoma cells into the pinna to address two questions: (1) does SL plus wide excision of the primary tumor result in a survival advantage over wide excision alone; and (2) do melanoma cells growing within lymph nodes produce a higher incidence of hematogenous metastases than do cells growing at the primary tumor site? We found that SL significantly improved the survival of mice with small primary tumors. We found no difference in the incidence of lung metastases produced by B16-BL6 melanoma cells growing exclusively within regional lymph nodes and cells growing within the pinna.

AB - Lymphatic mapping and sentinel lymph node biopsy-also termed sentinel lymphadenectomy (SL)-has become a standard of care for patients with primary invasive cutaneous melanoma. This technique has been shown to provide accurate information about the disease status of the regional lymph node basins at risk for metastasis, provide prognostic information, and provide durable regional lymph node control. The potential survival benefit afforded to patients undergoing SL is controversial. Central to this controversy is whether metastasis to regional lymph nodes occurs independent of or prior to widespread hematogenous dissemination. A related area of uncertainty is whether tumor cells residing within regional lymph nodes have increased metastatic potential. We have used a murine model of primary invasive cutaneous melanoma based on injection of B16-BL6 melanoma cells into the pinna to address two questions: (1) does SL plus wide excision of the primary tumor result in a survival advantage over wide excision alone; and (2) do melanoma cells growing within lymph nodes produce a higher incidence of hematogenous metastases than do cells growing at the primary tumor site? We found that SL significantly improved the survival of mice with small primary tumors. We found no difference in the incidence of lung metastases produced by B16-BL6 melanoma cells growing exclusively within regional lymph nodes and cells growing within the pinna.

KW - Lymph node metastasis

KW - Melanoma

KW - Sentinel lymph node biopsy

KW - Sentinel lymphadenectomy

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=42449139493&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42449139493&partnerID=8YFLogxK

U2 - 10.1007/s10585-008-9141-y

DO - 10.1007/s10585-008-9141-y

M3 - Article

C2 - 18264782

AN - SCOPUS:42449139493

VL - 25

SP - 191

EP - 199

JO - Clinical and Experimental Metastasis

JF - Clinical and Experimental Metastasis

SN - 0262-0898

IS - 3

ER -